PHARMA LIGHT

International Pharmaceutical Business, Technology, FDA Rules and Regulations, MHRA and other News for Indian Pharmacists, Pharmaceutical Companies.

Pages

▼

Showing posts with label HCV. Show all posts

Showing posts with label HCV. Show all posts

FDA ACCEPT NDA For VIEKIRA PAK

AbbVie a global biopharmaceutical company, announced its New Drug Application (NDA) has been accepted by the U.S. Food and Drug Administr...

AbbVie Announces Phase 2 Studies ABT-493

AbbVie announced data from the SURVEYOR studies of its investigational HCV regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, ...

Roche expands cobas 4800 System menu

Roche announced the commercial availability of the cobas HIV-1, HCV and HCV Genotyping (GT) assays in countries accepting the CE mark. Th...

View web version

Powered by Blogger.